Stay updated with breaking news from Amyloid Beta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study this week points to a potential transmission risk of Alzheimer’s disease. Researchers found evidence in mice that an inherited form of the neurological disorder can be passed on via bone marrow donation. While such a danger has yet to be confirmed in humans and likely to be infrequent if it can happen, the authors say more research has to be done to investigate the possibility.
Patients who received contaminated growth hormone developed AD decades later. The study suggests AD is transmissible, but researchers stress it cannot be transmitted through routine medical care.
Researchers may have made a breakthrough in detecting Alzheimer’s disease through a simple blood test at an early stage.
Researchers explored how Death Induced by Survival gene Elimination through the analysis of RNA-induced silencing complex-bound short RNAs in Alzheimer's disease models influences neuronal survival and correlates with neurotoxicity in AD.
Eisai Co. Ltd. and Oita University in Oita Prefecture, Japan, developed a first-of-its-kind machine learning model to predict amyloid beta accumulation in the brain using a wristband sensor. The model, which collects biological and lifestyle data from daily life, is expected to enable screening for brain amyloid beta accumulation to identify those at risk for Alzheimer's disease, particularly because amyloid beta begins to accumulate in the brain about 20 years before the onset of the disease.